@FierceBiotech: Lilly upgrades its NYC research hub, adding 50 jobs in an immuno-oncology push. News | Follow @FierceBiotech
@JohnCFierce: How many big swings and misses does John Lechleiter get at $LLY? | Follow @JohnCFierce
@DamianFierce: Tired of writing about $LLY today so here's a hypoglycemia deal you can read about yourself. Press release | Follow @DamianFierce
> Radius Health's ($RDUS) in-development osteoporosis treatment reduced the rate of major fractures by 70% compared with placebo in a Phase III trial, the company said. News
> The FDA removed a partial clinical hold on Biodel's ($BIOD) Type 2 diabetes treatment, allowing the company to move forward with a Phase II study. Item
> Spark Therapeutics ($ONCE) added more positive results to its previously disclosed Phase III data, noting that its gene therapy for retinal disease improved functional function and light sensitivity. More
Medical Device News
@FierceMedDev: ICYMI Friday: Procyrion raises $10M to get minimally invasive mini heart pump in the clinic. Article | Follow @FierceMedDev
@VarunSaxena2: ICYMI last week from #AdvaMed15: CMS has 30 people to evaluate 30,000 diagnostic tests, but more FDA oversight is likely. More | Follow @VarunSaxena2
@EmilyWFierce: The latest from Advera Health Analytics on Alzheimer's drug safety. ICYMI from FiercePharma | Follow @EmilyWFierce
> NuVasive gets FDA blessing for spinal cord surgical device. Report
> Clinicians criticize Baxter for suspending comparative drug/device heart failure trial. More
> Neurosurgeons hope brain implants can be used to treat array of mental disorders. Article
Pharma News
@FiercePharma: Study: Elephants rarely get cancer--and that could boost human oncology research. FierceAnimalHealth story | Follow @FiercePharma
@EricPFierce: ICYMI from FiercePharmaManufacturing: Sanofi's Kansas City, MO, plant back on the block as its August 2016 closing looms. Story | Follow @EricPFierce
@CarlyHFierce: Backlash rages on over Purdue's pediatric OxyContin approval. Story | Follow @CarlyHFierce
> BMS' Opdivo gets a jump on Keytruda with another early FDA approval. Article
> Price hikes aren't always sustainable: Just ask Mallinckrodt about Ofirmev. More
> Takeda keeps Actos settlement ball rolling with two new resolutions. Report
Animal Health News
> Study: Elephants rarely get cancer--and that could boost human oncology research. More
> Ceva urges mass vaccination against bird flu at global animal-health gathering. Story
> FDA seeks comments on potential scheduling change for ketamine. Item
> California sets strictest U.S. standards for antibiotics use in livestock. Article
> CalTech team creates one-time contraceptive vaccine for feral animals. Report
Biotech IT News
> NIH gives UCSF $10M to build mobile data collection platform. News
> GSK finds 21M mentions of its drugs in trawl of social media. Report
> ResearchKit-enabled project sets out to track real-world effectiveness of hep C drugs. Story
> UBiome taps Apple ecosystem to broaden microbiome data-gathering drive. Article
> Is Google a competitor or partner to Big Pharma? Roche's CEO doesn't know, yet. More
Pharma Marketing News
> Baxalta joins biosim makers eyeing a piece of AbbVie's Humira. More
> Biogen's top commercial exec leaves amid Tecfidera sales trouble. Report
> Roche leads the pack at ECTRIMS with standout data on new MS drug. Item
> Bill seeks to add nurse practitioners, PAs to Sunshine Act reporting. Story
> Pharma's digital desires thwarted by clunky organizations, lack of skilled employees. Article